Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 841951, 3 pages
http://dx.doi.org/10.1155/2014/841951
Editorial

Carbapenemases in Gram-Negative Bacteria: Laboratory Detection and Clinical Significance

1Clinical Department for Clinical and Molecular Microbiology, University Hospital Center Zagreb, 10000 Zagreb, Croatia
2Department of Microbiology, School of Medicine, University of Zagreb, 10000 Zagreb, Croatia
3Department of Microbiology, University Hospital Center Split, 21000 Split, Croatia
4Cantonal Public Health Institute Zenica, 72000 Zenica, Bosnia and Herzegovina
5Department for Sanitary Engineering, Faculty of Health Sciences, 1000 Ljubljana, Slovenia

Received 24 May 2014; Accepted 24 May 2014; Published 15 June 2014

Copyright © 2014 Branka Bedenić et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. M. Papp-Wallace, A. Endimiani, M. A. Taracila, and R. A. Bonomo, “Carbapenems: past, present, and future,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 11, pp. 4943–4960, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. M. Queenan and K. Bush, “Carbapenemases: the versatile β-lactamases,” Clinical Microbiology Reviews, vol. 20, no. 3, pp. 440–458, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. M. Diene and J. M. Rolain, “Carbapenemase genes and genetic platforms in Gram-negative bacilli: Enterobacteriaceae, Pseudomonas, and Acinetobacter species (E.P.A),” Clinical Microbiology and Infection, 2014. View at Publisher · View at Google Scholar
  4. L. S. Munoz-Price, L. Poirel, R. A. Bonomo et al., “Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases,” The Lancet Infectious Diseases, vol. 13, no. 9, pp. 785–796, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. S. Tzouvelekis, A. Markogiannakis, M. Psichogiou, P. T. Tassios, and G. L. Daikos, “Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions,” Clinical Microbiology Reviews, vol. 25, no. 4, pp. 682–707, 2012. View at Publisher · View at Google Scholar · View at Scopus
  6. T. R. Walsh, “Emerging carbapenemases: a global perspective,” International Journal of Antimicrobial Agents, vol. 36, supplement 3, pp. S8–S14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Cantón, M. Akóva, Y. Carmeli et al., “Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe,” Clinical Microbiology and Infection, vol. 18, no. 5, pp. 413–431, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Poirel, C. Hombrouck-Alet, C. Freneaux, S. Bernabeu, and P. Nordmann, “Global spread of New Delhi metallo-β-lactamase 1,” The Lancet Infectious Diseases, vol. 10, no. 12, p. 832, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. P. Espina, L. Poirel, Y. Carmeli et al., “Spread of NDM-2-producing Acinetobacter baumannii in the Middle East,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 8, Article ID dkt109, pp. 1928–1930, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Nakazawa, R. Ii, T. Tamura et al., “A case of NDM-1-producing Acinetobacter baumannii transferred from India to Japan,” Journal of Infection and Chemotherapy, vol. 19, no. 2, pp. 330–332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. T. R. Walsh, J. Weeks, D. M. Livermore, and M. A. Toleman, “Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study,” The Lancet Infectious Diseases, vol. 11, no. 5, pp. 355–362, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Jovcic, Z. Lepsanovic, V. Suljagic et al., “Emergence of NDM-1 metallo-β-lactamase in Pseudomonas aeruginosa clinical isolates from Serbia,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 8, pp. 3929–3931, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Mazzariol, Z. Bošnjak, P. Ballarini et al., “NDM-1-producing Klebsiella pneumoniae, Croatia,” Emerging Infectious Diseases, vol. 18, no. 3, pp. 532–534, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. B. A. Evans and S. G. Amyes, “OXA β-lactamases,” Clinical Microbiology Reviews, vol. 27, no. 2, pp. 241–263, 2014. View at Google Scholar
  15. L. Poirel, C. Héritier, V. Tolün, and P. Nordmann, “Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae,” Antimicrobial Agents and Chemotherapy, vol. 48, no. 1, pp. 15–22, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. G. Cuzon, J. Ouanich, R. Gondret, T. Naas, and P. Nordmann, “Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 5, pp. 2420–2423, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Akova, G. L. Daikos, L. Tzouvelekis, and Y. Carmeli, “Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria,” Clinical Microbiology and Infection, vol. 18, no. 5, pp. 439–448, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Miriagou, G. Cornaglia, M. Edelstein et al., “Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues,” Clinical Microbiology and Infection, vol. 16, no. 2, pp. 112–122, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Nordmann, M. Gniadkowski, C. G. Giske, L. Poirel, N. Woodford, and V. Miriagou, “Identification and screening of carbapenemase-producing Enterobacteriaceae,” Clinical Microbiology and Infection, vol. 18, no. 5, pp. 432–438, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. T. D. Huang, C. Berhin, P. Bogaerts, and Y. Glupczynski, “Evaluation of avibactam-supplemented combination disk tests for the detection of OXA-48 carbapenemase-producing Enterobacteriaceae,” Diagnostic Microbiology and Infectious Diseases, vol. 79, no. 2, pp. 252–254, 2014. View at Publisher · View at Google Scholar
  21. A. Johansson, J. Ekelöf, C. G. Giske, and M. Sundqvist, “The detection and verification of carbapenemases using ertapenem and Matrix Assisted Laser Desorption Ionization-Time of Flight,” BMC Microbiology, vol. 14, no. 1, article 89, 2014. View at Google Scholar
  22. “Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE),” (Klebsiella pneumoniae in Healthcare Settings), http://www.cdc.gov.
  23. J. D. Siegel, E. Rhinehgart, M. Jackson, and L. Chiarello, Healthcare Infection Control Practices Advisory Committee. Managment of Multidrug Resistant Organisms in Healthcare Settings, CDC, Atlanta, Ga, USA, 2006.
  24. Guidance for Control of Carbapenem-Resistant Enterobacteriacae (CRE), CRE Toolkit, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Promotion, CDC, Atlanta, Ga, USA, 2012.